# Filing Detail

Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001193125-25-074629
Filing Date
2025-04-07
Accepted
2025-04-07 16:32:27
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PREC14A | d941014dprec14a.htm | PREC14A | 355354
2 | GRAPHIC | g941014g48g48.jpg | GRAPHIC | 276452
3 | GRAPHIC | g941014g49g49.jpg | GRAPHIC | 292391
| Complete submission text file | 0001193125-25-074629.txt |  | 1140725

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-34207 | Film No.: 25818600
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Filed by) CIK: 0001856083 (see all company filings)

EIN.: 853360885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A